Arteriovenous Vascular Access Selection and Evaluation

MacRae, Jennifer M.; Oliver, Matthew J.; Clark, Edward G.; Dipchand, Christine; Kappel, Joanne; Kiaii, Mercedeh; Luscombe, Rick; Miller, Lisa; Moist, Louise

doi:10.1177/2054358116669125

Cited by 37 publications

(25 citation statements)

References 83 publications

(103 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, caution should be exercised when applying risk models to specific patient populations as widespread applicability is limited. 10 Furthermore, surgical factors such as extent of surgical training, 11 the type of anesthesia during access creation, 12 and the anastomosis angle 13 may also impact primary failure rates (see “Impact of Primary Failure” section in MacRae et al 14 ).…”

Section: Arteriovenous Fistula Primary Failurementioning

confidence: 99%

Arteriovenous Access Failure, Stenosis, and Thrombosis

MacRae

Dipchand

Oliver

et al. 2016

Can J Kidney Health Dis

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Arteriovenous Fistula Primary Failurementioning

confidence: 99%

Arteriovenous Access Failure, Stenosis, and Thrombosis

MacRae

Dipchand

Oliver

et al. 2016

Can J Kidney Health Dis

Self Cite

View full text Add to dashboard Cite

show abstract

“…In 20% of cases, restenosis occurs within 1 week post-procedure and 40% in 1 month. 3,4,5 www.journal.vascular.co.id 5…”

Section: Introductionmentioning

confidence: 99%

Effect of Venoplasty on Arteriovenous Fistula Dysfunction on Quick of Blood Values of Hemodialysis Patients

Wuwu

Tjandra

Sumangkut

et al. 2021

JINASVS

View full text Add to dashboard Cite

Introduction: Percutaneous transluminal angioplasty (PTA) is the gold standard in the management of AVF dysfunction. On the other hand, the management of stenosis with PTA induces an acceleration of neointimal hyperplasia with the occurrence of restenosis. The aim of this study was to assess the increase of quick of blood (Qb) hemodialysis (HD) patients after venoplasty with AVF dysfunction and its patency within 3 months post procedure, and examine the factors associated with venoplasty failure to maintain optimal Qb. Method: This study used a quasi-experimental design, in which all subjects received the treatment under study without a control group, due to ethical issues; because venoplasty is the standard protocol for AVF dysfunction in the place of this study. Qb measurements were made before and after HD, and 3 months thereafter, to evaluate AVF patency. Result: There were 25 cases that included 23 patients with 2 patients had to be re- venoplasty. An increase in Qb averaged 221.3−196.7 mL / min or about 25 mL / min in the 3-month period after venoplasty with significant results (p = 0.044). The location of stenosis in juxta anastomosis has a 14 times greater chance of venoplasty failure (p = 0.037) than stenosis in the area of draining vein or central vein. Diabetes Mellitus (DM) increased the odds of venoplasty failure 12 times greater (p = 0.038) than cases without this comorbid.. Conclusion: This study proves the increase in Qb of hemodialysis patients after venoplasty for AVF dysfunction, and it was found that the location of juxta anastomosis stenosis and the presence of DM are the two main factors that have the potential to increase the chance of venoplasty failure.

show abstract

“…This complication also highlights the need to reduce catheter dependence in hemodialysis patients, as has been advocated by all professional societies and more recently spearheaded by the Fistula First Initiative[18, 19]. Unfortunately, for various reasons including patient factors[2, 20], long term catheter use remains quite common, and, as a consequence, the need to recognize and appropriately handle embedded catheters remains of paramount importance.…”

Section: Discussionmentioning

confidence: 99%

Endoluminal dilatation for embedded hemodialysis catheters: A case-control study of factors associated with embedding and clinical outcomes

et al. 2017

Self Cite

View full text Add to dashboard Cite

BackgroundWith the increasing frequency of tunneled hemodialysis catheter use there is a parallel increase in the need for removal and/or exchange. A small but significant minority of catheters become embedded or ‘stuck’ and cannot be removed by traditional means. Management of embedded catheters involves cutting the catheter, burying the retained fragment with a subsequent increased risk of infections and thrombosis. Endoluminal dilatation may provide a potential safe and effective technique for removing embedded catheters, however, to date, there is a paucity of data.Objectives1) To determine factors associated with catheters becoming embedded and 2) to determine outcomes associated with endoluminal dilatationMethodsAll patients with endoluminal dilatation for embedded catheters at our institution since Jan. 2010 were included. Patients who had an embedded catheter were matched 1:3 with patients with uncomplicated catheter removal. Baseline patient and catheter characteristics were compared. Outcomes included procedural success and procedure-related infection. Logistic regression models were used to determine factors associated with embedded catheters.ResultsWe matched 15 cases of embedded tunneled catheters with 45 controls. Among patients with embedded catheters, there were no complications with endoluminal dilatation. Factors independently associated with embedded catheters included catheter dwell time (> 2 years) and history of central venous stenosis.ConclusionEmbedded catheters can be successfully managed by endoluminal dilatation with minimal complications and factors associated with embedding include dwell times > 2 years and/or with a history of central venous stenosis.

show abstract

Arteriovenous Vascular Access Selection and Evaluation

Cited by 37 publications

References 83 publications

Arteriovenous Access Failure, Stenosis, and Thrombosis

Arteriovenous Access Failure, Stenosis, and Thrombosis

Effect of Venoplasty on Arteriovenous Fistula Dysfunction on Quick of Blood Values of Hemodialysis Patients

Endoluminal dilatation for embedded hemodialysis catheters: A case-control study of factors associated with embedding and clinical outcomes

Contact Info

Product

Resources

About